Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond

The recent FDA approval of the neurosteroid, brexanolone (allopregnanolone), as a treatment for women with postpartum depression, and successful trials of a related neuroactive steroid, SGE-217, for men and women with major depressive disorder offer the hope of a new era in treating mood and anxiety...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neurobiol Stress
Главные авторы: Zorumski, Charles F., Paul, Steven M., Covey, Douglas F., Mennerick, Steven
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2019
Предметы:
Articles from the Special Issue on Allopregnanolone role in the neurobiology of stress and mood disorders; Edited by Graziano Pinna
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804800/
https://ncbi.nlm.nih.gov/pubmed/31649968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ynstr.2019.100196
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы